Annual ROA
-92.23%
-18.00%-24.25%
31 December 2023
Summary:
Esperion Therapeutics annual return on assets is currently -92.23%, with the most recent change of -18.00% (-24.25%) on 31 December 2023. During the last 3 years, it has fallen by -41.66% (-82.38%). ESPR annual ROA is now -306.48% below its all-time high of -22.69%, reached on 31 December 2015.ESPR ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-29.58%
+5.92%+16.68%
30 September 2024
Summary:
Esperion Therapeutics quarterly return on assets is currently -29.58%, with the most recent change of +5.92% (+16.68%) on 30 September 2024. Over the past year, it has increased by +52.56% (+63.99%). ESPR quarterly ROA is now -84.64% below its all-time high of -16.02%, reached on 31 December 2015.ESPR Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESPR ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.3% | +64.0% |
| 3 y3 years | -82.4% | +73.4% |
| 5 y5 years | +3.7% | +26.7% |
ESPR ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -82.4% | at low | at high | +73.4% |
| 5 y | 5 years | -82.4% | +3.7% | at high | +73.4% |
| alltime | all time | -306.5% | +62.7% | -84.6% | +81.6% |
Esperion Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -29.58%(-16.7%) |
| June 2024 | - | -35.50%(+5.6%) |
| Mar 2024 | - | -33.62%(-62.7%) |
| Dec 2023 | -92.23%(+24.2%) | -90.08%(+9.7%) |
| Sept 2023 | - | -82.14%(-0.1%) |
| June 2023 | - | -82.25%(+0.6%) |
| Mar 2023 | - | -81.76%(+11.2%) |
| Dec 2022 | -74.23%(+1.4%) | -73.52%(-5.3%) |
| Sept 2022 | - | -77.65%(-7.5%) |
| June 2022 | - | -83.94%(+7.8%) |
| Mar 2022 | - | -77.85%(-12.1%) |
| Dec 2021 | -73.24%(+44.8%) | -88.57%(-20.3%) |
| Sept 2021 | - | -111.07%(+2.2%) |
| June 2021 | - | -108.63%(+93.7%) |
| Mar 2021 | - | -56.09%(+3.8%) |
| Dec 2020 | -50.57%(-6.9%) | -54.02%(+31.6%) |
| Sept 2020 | - | -41.04%(+26.0%) |
| June 2020 | - | -32.58%(-70.4%) |
| Mar 2020 | - | -109.99%(+187.3%) |
| Dec 2019 | -54.30%(-43.3%) | -38.29%(-5.1%) |
| Sept 2019 | - | -40.36%(+13.4%) |
| June 2019 | - | -35.60%(-0.3%) |
| Mar 2019 | - | -35.72%(-65.8%) |
| Dec 2018 | -95.81% | -104.49%(+31.9%) |
| Sept 2018 | - | -79.24%(+18.4%) |
| June 2018 | - | -66.91%(-1.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | -67.65%(+0.3%) |
| Dec 2017 | -63.85%(+130.3%) | -67.42%(+2.2%) |
| Sept 2017 | - | -65.98%(+15.1%) |
| June 2017 | - | -57.32%(+42.1%) |
| Mar 2017 | - | -40.33%(+44.2%) |
| Dec 2016 | -27.73%(+22.2%) | -27.96%(+32.7%) |
| Sept 2016 | - | -21.07%(+12.6%) |
| June 2016 | - | -18.72%(+6.5%) |
| Mar 2016 | - | -17.58%(+9.7%) |
| Dec 2015 | -22.69%(-30.9%) | -16.02%(-5.3%) |
| Sept 2015 | - | -16.91%(-17.1%) |
| June 2015 | - | -20.41%(-23.6%) |
| Mar 2015 | - | -26.72%(-37.0%) |
| Dec 2014 | -32.83%(-46.1%) | -42.38%(-19.4%) |
| Sept 2014 | - | -52.61%(+25.0%) |
| June 2014 | - | -42.10%(-9.8%) |
| Mar 2014 | - | -46.69%(-7.5%) |
| Dec 2013 | -60.95%(-75.4%) | -50.49%(-10.7%) |
| Sept 2013 | - | -56.52%(-46.5%) |
| June 2013 | - | -105.60%(+15.4%) |
| Mar 2013 | - | -91.50%(-43.0%) |
| Dec 2012 | -247.40%(+512.8%) | -160.58% |
| Dec 2011 | -40.37%(-8.8%) | - |
| Dec 2002 | -44.28%(+38.7%) | - |
| Dec 2001 | -31.92%(-50.3%) | - |
| Dec 2000 | -64.22%(-51.9%) | - |
| Dec 1999 | -133.39% | - |
FAQ
- What is Esperion Therapeutics annual return on assets?
- What is the all time high annual ROA for Esperion Therapeutics?
- What is Esperion Therapeutics annual ROA year-on-year change?
- What is Esperion Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly ROA year-on-year change?
What is Esperion Therapeutics annual return on assets?
The current annual ROA of ESPR is -92.23%
What is the all time high annual ROA for Esperion Therapeutics?
Esperion Therapeutics all-time high annual return on assets is -22.69%
What is Esperion Therapeutics annual ROA year-on-year change?
Over the past year, ESPR annual return on assets has changed by -18.00% (-24.25%)
What is Esperion Therapeutics quarterly return on assets?
The current quarterly ROA of ESPR is -29.58%
What is the all time high quarterly ROA for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly return on assets is -16.02%
What is Esperion Therapeutics quarterly ROA year-on-year change?
Over the past year, ESPR quarterly return on assets has changed by +52.56% (+63.99%)